All patients
Patient Record · MRN SMC-432402
SYN-074
[SYN] India Fornax · 71y · Female · Chinese · BMI 28.7 · ECOG 1
SVMC - Sunway Velocity · Medical Oncology · Dr. Kavitha Sundaram
IVB (T4, N3, M1c)Partial Response
EGFR Exon 20 InsTP53
Clinical storyline
[SYN] India Fornax, a 71-year-old Chinese female (never, ECOG 1), presented in 2023-12 with unintentional weight loss (~5kg over 3 months). Workup confirmed Adenocarcinoma (Stage IV, EGFR Exon 20 Ins). The MDT recommended first-line osimertinib. Current status: Partial Response.
HPE Results
Poorly differentiated NSCLC adenocarcinoma, EGFR Exon 20 insertion
Clinical Stage
IVB (T4, N3, M1c)
Pathological Stage
IVB (T4, N3, M1c)
Adenocarcinoma Subtype
Poorly differentiated adenocarcinoma
CEA (ng/mL)
189.0
Tumor (CT/PET)
9.1 cm
PET SUV
14.43
NGS Results
1. EGFR Exon 20 Insertion 2. TP53 H193R